HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 254: | Line 254: | ||
|[[HAEM5:Acute promyelocytic leukaemia with PML::RARA fusion|Acute promyelocytic leukaemia with PML::RARA fusion]] | |[[HAEM5:Acute promyelocytic leukaemia with PML::RARA fusion|Acute promyelocytic leukaemia with PML::RARA fusion]] | ||
|Disease | |Disease | ||
| | |(Rabail Aslam, MD) | ||
| | |7/1/24 | ||
| | | | ||
| | | | ||
| Line 350: | Line 350: | ||
|[[HAEM5:Acute myeloid leukaemia with KMT2A rearrangement|Acute myeloid leukaemia with KMT2A rearrangement]] | |[[HAEM5:Acute myeloid leukaemia with KMT2A rearrangement|Acute myeloid leukaemia with KMT2A rearrangement]] | ||
|Disease | |Disease | ||
| | |(Rabail Aslam, MD) | ||
| | |7/1/24 | ||
| | | | ||
| | | | ||
| Line 510: | Line 510: | ||
|[[HAEM5:Acute basophilic leukaemia|Acute basophilic leukaemia]] | |[[HAEM5:Acute basophilic leukaemia|Acute basophilic leukaemia]] | ||
|Disease | |Disease | ||
| | |Ashwini Yenamandra PhD FACMG | ||
| | |5/1/24 | ||
| | | | ||
| | | | ||
| Line 558: | Line 558: | ||
|[[HAEM5:Acute erythroid leukaemia|Acute erythroid leukaemia]] | |[[HAEM5:Acute erythroid leukaemia|Acute erythroid leukaemia]] | ||
|Disease | |Disease | ||
| | |Ashwini Yenamandra PhD FACMG | ||
| | |5/1/24 | ||
| | | | ||
| | | | ||
| Line 625: | Line 625: | ||
|[[HAEM5:Myeloid neoplasm post cytotoxic therapy|Myeloid neoplasm post cytotoxic therapy]] | |[[HAEM5:Myeloid neoplasm post cytotoxic therapy|Myeloid neoplasm post cytotoxic therapy]] | ||
|Disease | |Disease | ||
| | |(Rabail Aslam, MD) | ||
| | |7/1/24 | ||
| | | | ||
| | | | ||
| Line 836: | Line 836: | ||
|[[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid|Mixed-phenotype acute leukaemia, B/myeloid]] | |[[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid|Mixed-phenotype acute leukaemia, B/myeloid]] | ||
|Disease | |Disease | ||
| | |(Rabail Aslam, MD) | ||
| | |7/1/24 | ||
| | | | ||
| | | | ||
| Line 868: | Line 868: | ||
|[[HAEM5:Mixed-phenotype acute leukaemia, rare types|Mixed-phenotype acute leukaemia, rare types]] | |[[HAEM5:Mixed-phenotype acute leukaemia, rare types|Mixed-phenotype acute leukaemia, rare types]] | ||
|Disease | |Disease | ||
| | |Daynna Wolff, PhD | ||
| | |5/9/24 | ||
| | | | ||
| | | | ||
| Line 900: | Line 900: | ||
|[[HAEM5:Acute undifferentiated leukaemia|Acute undifferentiated leukaemia]] | |[[HAEM5:Acute undifferentiated leukaemia|Acute undifferentiated leukaemia]] | ||
|Disease | |Disease | ||
| | |(Rabail Aslam, MD) | ||
| | |7/1/24 | ||
| | | | ||
| | | | ||